Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Do-Coop Technologies is an Israeli biotechnology company specializing in the development of Neowater, a proprietary platform technology that modifies the physical properties of water to mimic the structured environment of biological systems. By creating stable hydration shells around inorganic cores, Neowater enhances the solubility, stability, and biological activity of molecules such as proteins, enzymes, and DNA. The company's products are widely used as reagents to improve the efficiency and sensitivity of PCR, cell culture, and various diagnostic assays. Beyond research tools, Do-Coop explores the application of its technology in drug delivery systems and the stabilization of active pharmaceutical ingredients. The company operates as a platform-based entity, providing solutions for the life sciences, cosmetics, and industrial sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Do-Coop Technologies.